English
Specials
    Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsWorldTeva to hold Indivior generic drug launch pending US ruling

    Teva to hold Indivior generic drug launch pending US ruling

    The pair's Indian rival Dr.Reddy's Laboratories is currently locked in a legal battle in the United States to re-launch a cheaper version of the UK drugmaker's Suboxone Film.

    Reuters
    September 12, 2018 / 12:47 IST

    Teva Pharmaceuticals has agreed to hold off launching its knock-off version of Indivior Plc's blockbuster opioid addiction drug until the resolution of a US Court case on another generic rival, Indivior said on Wednesday.

    The pair's Indian rival Dr.Reddy's Laboratories is currently locked in a legal battle in the United States to re-launch a cheaper version of the UK drugmaker's Suboxone Film.

    Indivior also reiterated its full-year net revenues guidance of $25 million to $50 million from its new opioid addiction drug Sublocade, on which the company has pinned its hopes after the legal battles.

    Reuters
    first published: Sep 12, 2018 12:45 pm

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347